QA: Moleculin Biotech Inc. in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001659617_2021_Moleculin_Biotech_Inc.pdf

Logs

info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001659617')"}

Graph

Absolute values for 0001659617, Moleculin Biotech Inc.

  xvar xval
0 AssetsCurrent 17,198,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 483,000
3 remainder_Assets 11,350,000
4 LiabilitiesCurrent 2,920,000
5 LiabilitiesNoncurrent 159,000
6 remainder_Liabilities 8,192,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 6,785,000
9 ResearchAndDevelopmentExpense 12,757,000
10 remainder_Expenses -2,146,000
11 remainder_Revenues 0
12 remainder_NetIncome 41,000
13 remainder_ComprehensiveNetIncome 34,000
  yvar yval
0 Assets 29,031,000
1 Liabilities 11,271,000
2 Expenses 17,396,000
3 Revenues 0
4 StockholdersEquity 17,760,000
5 NetIncome -17,355,000
6 ComprehensiveNetIncome -17,338,000
7 BaseVar 28,886,500
8 EconomicCapitalRatio 0.656

Edgar->Model Mapping

Feature Distribution

Change over Time